These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 21226667

  • 1. Pentraxins and atherosclerosis: the role of PTX3.
    Garlanda C, Bottazzi B, Moalli F, Deban L, Molla F, Latini R, Mantovani A.
    Curr Pharm Des; 2011; 17(1):38-46. PubMed ID: 21226667
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3.
    Mantovani A, Garlanda C, Doni A, Bottazzi B.
    J Clin Immunol; 2008 Jan; 28(1):1-13. PubMed ID: 17828584
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pattern recognition by pentraxins.
    Agrawal A, Singh PP, Bottazzi B, Garlanda C, Mantovani A.
    Adv Exp Med Biol; 2009 Jan; 653():98-116. PubMed ID: 19799114
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pentraxins: multifunctional proteins at the interface of innate immunity and inflammation.
    Deban L, Bottazzi B, Garlanda C, de la Torre YM, Mantovani A.
    Biofactors; 2009 Jan; 35(2):138-45. PubMed ID: 19449441
    [Abstract] [Full Text] [Related]

  • 10. The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases.
    Norata GD, Garlanda C, Catapano AL.
    Trends Cardiovasc Med; 2010 Feb; 20(2):35-40. PubMed ID: 20656213
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pentraxins in innate immunity and inflammation.
    Garlanda C, Bottazzi B, Salvatori G, De Santis R, Cotena A, Deban L, Maina V, Moalli F, Doni A, Veliz-Rodriguez T, Mantovani A.
    Novartis Found Symp; 2006 Feb; 279():80-6; discussion 86-91, 216-9. PubMed ID: 17278387
    [Abstract] [Full Text] [Related]

  • 15. Pentraxins in innate immunity: lessons from PTX3.
    Deban L, Jaillon S, Garlanda C, Bottazzi B, Mantovani A.
    Cell Tissue Res; 2011 Jan; 343(1):237-49. PubMed ID: 20683616
    [Abstract] [Full Text] [Related]

  • 16. Long pentraxin 3 (PTX3) in the light of its structure, mechanism of action and clinical implications.
    Cieślik P, Hrycek A.
    Autoimmunity; 2012 Mar; 45(2):119-28. PubMed ID: 21988562
    [Abstract] [Full Text] [Related]

  • 17. Brain diseases and tumorigenesis: The good and bad cops of pentraxin3.
    Fornai F, Carrizzo A, Ferrucci M, Damato A, Biagioni F, Gaglione A, Puca AA, Vecchione C.
    Int J Biochem Cell Biol; 2015 Dec; 69():70-4. PubMed ID: 26485684
    [Abstract] [Full Text] [Related]

  • 18. Pentraxin 3, a non-redundant soluble pattern recognition receptor involved in innate immunity.
    Mantovani A, Garlanda C, Bottazzi B.
    Vaccine; 2003 Jun 01; 21 Suppl 2():S43-7. PubMed ID: 12763682
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.